Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sirolimus: a new immunosuppressant.

T Mukherjee1, B V Shah

  • 1PD Hinduja National Hospital and Medical Research Centre, Veer Savarkar Marg, Mahim, Mumbai 400 016, India.

The Journal of the Association of Physicians of India
|February 8, 2006
PubMed
Summary

Organ transplantation faces rejection challenges. Sirolimus, a novel immunosuppressant, shows promise in preventing and treating organ rejection, with additional antifungal and antitumor benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence for a Spectral Break or Curvature in the Spectrum of Astrophysical Neutrinos from 5 TeV to 10 PeV.

Physical review letters·2026
Same author

Search for Extremely-High-Energy Neutrinos and First Constraints on the Ultrahigh-Energy Cosmic-Ray Proton Fraction with IceCube.

Physical review letters·2025
Same author

Measurement of Atmospheric Neutrino Oscillation Parameters Using Convolutional Neural Networks with 9.3 Years of Data in IceCube DeepCore.

Physical review letters·2025
Same author

Search for an eV-Scale Sterile Neutrino Using Improved High-Energy ν_{μ} Event Reconstruction in IceCube.

Physical review letters·2024
Same author

Observation of Seven Astrophysical Tau Neutrino Candidates with IceCube.

Physical review letters·2024
Same author

Observation of high-energy neutrinos from the Galactic plane.

Science (New York, N.Y.)·2023

Area of Science:

  • Immunology
  • Pharmacology
  • Transplantation Medicine

Background:

  • Organ transplantation is a critical medical advancement but faces significant challenges with immune rejection.
  • Current immunosuppressants like cyclosporine, azathioprine, and corticosteroids are effective but have notable adverse effects.

Purpose of the Study:

  • To introduce Sirolimus, a novel immunosuppressant derived from a macrolide antibiotic.
  • To explore the potential role of Sirolimus in managing organ transplant rejection.
  • To highlight additional therapeutic properties of Sirolimus.

Main Methods:

  • Review of existing literature on Sirolimus and its pharmacological properties.
  • Analysis of Sirolimus's mechanism of action in the context of immunosuppression.
  • Examination of preclinical and clinical data regarding Sirolimus efficacy.

Main Results:

  • Sirolimus demonstrates potential efficacy in preventing organ transplant rejection.
  • Sirolimus may be effective in treating refractory cases of organ transplant rejection.
  • Sirolimus exhibits secondary benefits, including antifungal, antitumor, and anti-smooth muscle proliferative activities.

Conclusions:

  • Sirolimus represents a promising new agent in the field of organ transplantation.
  • Its multifaceted properties offer potential advantages over existing immunosuppressive therapies.
  • Further research into Sirolimus is warranted to fully elucidate its therapeutic applications.

Related Experiment Videos